FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 17 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $562,000 | -70.9% | 283,820 | -49.9% | 0.00% | -80.0% |
Q3 2021 | $1,931,000 | -78.7% | 566,207 | -49.1% | 0.01% | -61.5% |
Q2 2021 | $9,058,000 | +32.5% | 1,111,510 | +100.0% | 0.01% | -38.1% |
Q1 2021 | $6,836,000 | -32.1% | 555,778 | +0.8% | 0.02% | -34.4% |
Q4 2020 | $10,070,000 | +17.5% | 551,476 | +0.4% | 0.03% | +3.2% |
Q3 2020 | $8,572,000 | – | 549,154 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,379,843 | $11,246,000 | 2.62% |
Novo Holdings A/S | 2,361,229 | $19,244,000 | 0.85% |
Ally Bridge Group (NY) LLC | 401,747 | $3,274,000 | 0.81% |
SECTORAL ASSET MANAGEMENT INC | 640,714 | $5,222,000 | 0.42% |
FRAZIER MANAGEMENT LLC | 550,000 | $4,483,000 | 0.41% |
TFG Asset Management GP Ltd | 750,000 | $6,113,000 | 0.33% |
Eventide Asset Management | 2,485,656 | $19,757,000 | 0.26% |
AXA S.A. | 1,111,510 | $9,058,000 | 0.01% |
Woodline Partners LP | 25,932 | $211,000 | 0.00% |
WELLINGTON MANAGEMENT GROUP LLP | 2,001,951 | $16,315,000 | 0.00% |